Anthropic Opens a Wet Lab: Claude Steps From the Digital World Onto the Real Bench, Closing the Physical Loop of AI-Driven Discovery
Introduction: The Last Missing Piece of AI for Science
On September 18, Reuters reported that Anthropic has quietly built a biology wet lab in the San Francisco Bay Area and begun plugging Claude into real biological experiments MITT Technology Review. Eric Kauderer-Abrams, Anthropic’s head of life sciences, soon confirmed the news with a telling remark: “The ultimate test of biology is, and will remain, real laboratory work.” Multiple sources, including SiliconANGLE and Startup Fortune, corroborate the report SiliconANGLE.
This is not merely a signal that Anthropic is crossing into biomedicine. It is a landmark event in the profound transformation of AI for Science. Over the past few years, AI has mainly accelerated the “Design” phase — a model can generate thousands to tens of thousands of candidate molecules or protein sequences within hours. But the speed at which those designs can be validated in the physical world has not kept pace. DNA synthesis, protein expression, purification, binding assays, cell experiments — the wall-clock time of these physical flows has barely moved. The result is a structural bottleneck unique to AI-driven pharma: “designing faster and faster, validating slower and slower.”
Anthropic’s wet lab is aimed precisely at this bottleneck: taking the crucial physical-validation phase of the “design-build-test-learn” (DBTL) loop back into its own hands — and, further, letting Claude directly command robot cells to run experiments with only limited human intervention. This is the pivotal leap of AI from the digital world into physical experimental scenarios. In this article, written from an AI research-automation engineering angle, we dissect the technical architecture, closed-loop mechanisms, safety compliance, and industry coordinates of Anthropic’s wet lab.
1. Why “Building an In-House Wet Lab” Is an Engineering Decision, Not Just a Strategic Statement
To understand Anthropic’s move, you must first see the real predicament of the AI-pharma industry in 2026. Technology companies can now produce exquisite computational designs, but the physical validation behind those designs seriously lags.
Anthropic’s own experiment published in August vividly illustrated this contradiction. Claude Opus 4.8 and Mythos Preview designed protein binders against 15 targets; Adaptyv Bio and synthetic-biology firm Twist Bioscience then had to physically manufacture these “digital designs” and run independent wet-lab validation Anthropic Science. Eventually Claude successfully designed binding proteins for 14 of the 15 targets; in the experiment addressing all targets simultaneously, the hit rates reached 22.6% and 26.7% respectively — clearly above the roughly 10%–15% typical level cited for traditional protein-design projects MITT Technology Review.
The numbers are impressive, but the real pain point sits at the experimental end. Twist Bioscience’s order growth has already demonstrated this demand spillover — its AI-related orders grew from about $25 million in FY2025 to about $50 million in FY2026, and the company projects roughly $100 million in FY2027 MITT Technology Review. In other words, as the number of experimental batches grows, fully relying on external validation keeps stretching efficiency, cost, scheduling, and data-return latency. Building an in-house wet lab is essentially taking control of the feedback-loop cycle — the single most decisive system variable.
Now place this judgment in the industry landscape. Laboratory-automation players have already run several mature paradigms:
- Molecular-foundry paradigm: DeepCure’s robotic molecular foundry in Israel works on 96-well microtiter plates, using a Tecan Fluent 1080 liquid handler, a KX2 robotic arm, a Waters Prep LC AutoPurification system, and more, to autonomously synthesize, purify, and characterize lead-like compounds from a computer-generated compound list — targeting 5,000–10,000 new compounds per month DeepCure/SLAS.
- Self-driving-lab paradigm: UHN in Toronto, in a paper in Cell, unveiled LUMI-lab, which pretrains a LUMI foundation model on more than 28 million molecular structures to act as a “brain” that, combined with decision software and a suite of coordinated robotics, automatically runs experiments and iterates UHN Research.
- Laboratory-autonomy-OS paradigm: Insilico Medicine’s LabClaw is built on a lightweight Agent-Guard architecture with five collaborating agents (Experiment Coordinator, Orchestration Expert, Science Analyst, QC Inspector, Data Specialist) and 28 specialized skill modules, running on top of the fully automated LifeStar2 laboratory to close the loop from target discovery to report generation Insilico.
- Domestic autonomous-lab paradigm: XtalPi combines proprietary AI models with robotic automation — hundreds of workstations, AGV carts, and a 24/7 closed-loop DMTA (Design-Synthesis-Test-Analyze) cycle XtalPi.
The essential difference between Anthropic and these players is this: Anthropic is not building customization for a particular pharma. It is wiring the capability of a general-purpose foundation model directly to real physical experiments, letting Claude — a general intelligence — become the “orchestrator-in-chief” of an autonomous lab. This is closer to defining a universal “autonomous-research operating system” for the entire industry.
2. The Technical Base of the Wet Lab: From Heterogeneous Devices to a Unified Interface
Owning a lab is not the same as being able to control it. The biggest engineering challenge of a traditional lab is heterogeneity: liquid handlers, robotic arms, microscopes, and microplate readers from different vendors each have entirely different software and communication interfaces. They can each run autonomously but rarely form a unified system naturally. Wiring them together often takes engineers weeks or even months of bespoke work; and if every Claude decision still requires a human to physically move samples and set parameters between instruments, total throughput is once again gated by human speed.
Anthropic’s Model Hardware Standard (MHS), released in August, targets exactly this layer MITT Technology Review. MHS is best understood as a generic interface that lets an AI agent control physical devices:
- Unified state description: programmable devices such as microscopes, liquid handlers, and robotic arms tell the model, in a relatively unified way, what state they are currently in.
- Unified capability abstraction: exposing “which operations can be executed,” compressing the bespoke interface of each device into standardized capabilities the model can directly understand and invoke.
- Unified safety boundaries: making explicit to the model which safety boundaries each device must not cross.
In early testing, MHS had already shortened the integration time for some lab devices from weeks or months to hours or even minutes MITT Technology Review. In a BCA protein-concentration experiment at Genentech, Claude coordinated a liquid handler, a robotic arm, and a microplate reader: it not only executed the prescribed steps but adjusted parameters based on results, and in some cases the system could even diagnose and recover from hardware anomalies by itself. The University of Washington labs of David Baker and Sudarshan Pinglay then wired MHS into a more realistic research workflow — PhD student Zihao Song used it to connect dispersed lab devices, let Claude Code read real-time qPCR curves, pause experiments at critical nodes, and coordinate a robotic arm with liquid-handling equipment to transfer sample plates MITT Technology Review.
This unified-interface thinking is consolidating capabilities previously scattered across institutions — Claude thinking, external labs validating, data returning to Anthropic after a delay — into a single system. It is the engineering precondition that makes the entire wet-lab architecture viable.
Below is the physical facility topology of the wet lab (Figure 1):
Figure 1 Wet Lab Physical Facility Topology
+-------------------------------------------------------------+
| Wet Lab |
| |
| +----------+ +------------+ +------------+ |
| | Liquid |-> | Robotic Arm|-> | Incubator/ | |
| | Handler | +-----^------+ | Shaker | |
| +-----^----+ | transfers +-----^------+ |
| | | plates | |
| | v v |
| +-----+------------+ +------------------+ |
| | Plate Hotel |<->| Plate Reader | |
| | (barcode track) | | Microplate | |
| +-----^------------+ +--------+---------+ |
| | | data |
| +-----+------------+ +--------v---------+ |
| | LC-MS / Mass Spec| | Imaging Microscope| |
| | (characterization)| | | |
| +------------------+ +------------------+ |
| |
| +---------------------------------------+ |
| | Device Gateway Layer MHS (edge) | |
| | state/capability/safety -> unified | |
| +-------------------^-------------------+ |
+-----------------------|-------------------------------------+
| (controlled network / offline monitor)
+-----------+-----------+
| Claude Control System |
| (plan/decide/audit) |
+-----------------------+
The key point at the physical layer: every step must be reversible, auditable, and traceable. The barcode-tracked plate hotel ensures sample flow can be traced back; mass spec and imaging act as “sensors” that digitize the physical outcome for return; and the device-gateway layer abstracts these heterogeneous devices into a unified protocol for the Claude control system above. This differs fundamentally from the “tool calling” of a purely software agent — here every call corresponds to a physical operation in the real world, so idempotency and safety boundaries rise to a level of importance never seen before.
3. The Core Loop: Claude Plans → Robots Execute → Data Returns → Claude Iterates
The “soul” of the whole wet lab is the autonomous DBTL loop. If we cast Claude as an autonomous research agent in the physical world, it must simultaneously command four layers of capability:
- Protocol-planning layer: translate a scientific hypothesis into an executable experimental protocol.
- Instruction-compilation layer: compile human-readable protocols into robot-executable instruction streams (liquid volumes, well positions, temperatures, timings).
- Execution-feedback layer: read real-time experimental data from sensors (mass spec, imaging, qPCR).
- Learning-iteration layer: adjust the next round of design and protocol parameters based on results.
This is a canonical design-build-test-learn loop. Figure 2 shows its control and data flows:
Figure 2 Claude–Robot–Sensor Closed-Loop Architecture
+--------------+ hypothesis/goal +--------------------------+
| Scientist | ------------------> | Claude Protocol Planner |
| Human Handoff| | (interpret QID/target/ |
+--------------+ <------------------ | safety constraints) |
report/pause req +------------+-------------+
| protocol spec
v
+------------------------+
| Orchestrator / Dispatch|
| -> to Robot JSON |
+------------+----------+
| dispatch
+--------------------+------------+----------+----------------+
v v v v
+----------+ +----------+ +--------------+ +----------+
| Liquid | | Robotic | | Incubator / | | Reader |
| Handler | | Arm | | Temp Control | | / Mass |
+----+-----+ +----+-----+ +------+-------+ +----+-----+
| physically execute | | |
+----------+----------+-------------------+----------------+
v
+--------------------------+
| Data Acquisition/Return |
| Pipeline (sensor->struct)|
+------------+-------------+
| results
v
+--------------------------+
| Claude Analyze/Iterate |
| UpdatePrior -> Re-plan |
+------------+-------------+
| next-round protocol (closed loop)
v
+------------------+
| Fine-tune / RL |
+------------------+
3.1 Protocol Planning: Claude Turns Hypotheses Into Robot Instruction Streams
The core of planning is translating biological “intent” into machine “action sequences.” Below is a Python snippet showing the core structure of this “experiment protocol planner” — it receives a target and safety constraints, then emits a structured checklist of actions:
# protocol_planner.py
from dataclasses import dataclass, field
from typing import List, Optional
@dataclass
class LiquidStep:
op: str # "dispense" | "transfer" | "aspirate"
source: str # "reagent:A" -> well position
target: str
volume_ul: float
tip_config: str # multi/single, filter tips
safety_limits: dict = field(default_factory=dict)
@dataclass
class RobotAction:
station: str # "liq_handle" | "arm" | "incubator" | "reader"
command: str
params: dict
ack_required: bool = True # require sensor ack before next
@dataclass
class Protocol:
uid: str
steps: List[RobotAction]
checkpoint_gates: List[str] # ids needing human/QC approval
def plan_protocol(target, constraints) -> Protocol:
"""Claude-in-the-loop: translate hypothesis into action stream."""
liquid = [
LiquidStep(op="dispense", source=constraints["buffer"],
target=constraints["plate"], volume_ul=50.0),
LiquidStep(op="transfer", source=target["well"], target="reader",
volume_ul=10.0),
]
actions = [RobotAction(station="liq_handle", command="run",
params={"steps": [asdict(s) for s in liquid]},
ack_required=True)]
gates = constraints.get("checkpoint_gates", ["qc_od_600"])
return Protocol(uid=target["uid"], steps=actions, checkpoint_gates=gates)
The key design here is checkpoint_gates: at dangerous or critical nodes (e.g., OD600 absorbance quality control) the protocol forces a “human/QC approval” gate. This is the engineering embodiment of the idea that “AI can act freely within safe boundaries, but state changes require human confirmation” — highly isomorphic to the Agent-Guard / Human-in-the-Loop mechanism of Insilico’s LabClaw Insilico.
3.2 Task Scheduling: Automated Liquid-Handling Workflow
The physical core is the liquid handler. Below is a sketch of an “automated liquid-handling task scheduler” (Python), focusing on ordering constraints and fault recovery — the biggest difference from pure software tasks, since mis-sequencing a pipetting step can ruin an entire batch of samples:
# liq_scheduler.py
import heapq
from typing import Dict, List, Tuple
class LiquidWorkflowScheduler:
def __init__(self, stations: Dict[str, dict]):
self.stations = {s: dict(meta) for s, meta in stations.items()}
self._queue: List[Tuple[float, int, str, dict]] = []
def submit(self, job: dict, priority: int = 0):
heapq.heappush(self._queue, (self._eta(job), priority,
job["seq"], job))
def _eta(self, job: dict) -> float:
return self.stations[job["station"]]["free_at"]
def dispatch(self) -> List[str]:
done, tick = [], 0.0
while self._queue:
_, _, _, job = heapq.heappop(self._queue)
st = self.stations[job["station"]]
start = max(tick, st["free_at"])
dur = job["time_s"]
st["free_at"] = start + dur # occupy the station
tick = start
if job.get("retry") < job.get("max_retry", 2):
job["retry"] = job.get("retry", 0) + 1
job["time_s"] *= 1.5 # backoff
heapq.heappush(self._queue, (st["free_at"], 0, job["seq"], job))
done.append(f"{job['station']}:{job['seq']}@{start:.1f}s")
return done
This uses a priority queue (heapq) to model contention across multiple stations, with backoff retry on faults: when an instrument reports an error, the job is re-queued with exponential backoff instead of being dropped — corresponding to the MHS early-test ability for “Claude to diagnose and recover from partial hardware anomalies.”
3.3 Data Acquisition and Return Pipeline
Sensor data must be structured into a model-ready form. Below is a “wet-lab data acquisition and return pipeline” (Python), covering asynchronous ingestion, quality gating, and audited persistence:
# data_pipeline.py
import json, sqlite3, time
from dataclasses import asdict, dataclass
from typing import Dict, Optional
@dataclass
class Reading:
device: str
well: str
metric: str # "absorbance" | "mass" | "ct_value"
value: float
ts_ns: int
class WetDataPipeline:
def __init__(self, db_path: str):
self.conn = sqlite3.connect(db_path)
self._init_db()
def _init_db(self):
self.conn.execute("""CREATE TABLE IF NOT EXISTS readings(
device TEXT, well TEXT, metric TEXT, value REAL,
ts_ns INTEGER, qc_pass INTEGER)""")
def ingest(self, raw: Dict) -> Optional[Reading]:
ok = self._qc(raw) # quality gate before persist
r = Reading(device=raw["device"], well=raw["well"],
metric=raw["metric"], value=float(raw["value"]),
ts_ns=time.time_ns())
self.conn.execute(
"INSERT INTO readings VALUES(?,?,?,?,?,?)",
(r.device, r.well, r.metric, r.value, r.ts_ns, int(ok)))
self.conn.commit()
return r if ok else None
def _qc(self, raw: Dict) -> bool:
low, high = raw.get("limits", (0.0, float("inf")))
return low <= float(raw["value"]) <= high
This code reflects the difference between a wet-lab data pipeline and an ordinary one: every reading persisted must first pass a physically meaningful quality gate (QC) — e.g., an absorbance value outside the reasonable range is flagged as failed, preventing instrument artifacts from polluting the training set. Real-time qPCR and mass-spec data return happen through exactly such a “quality-gated + structured-persistence” pipeline.
3.4 The Iteration Controller of the Claude–Robot Loop
For the “learn” phase of the loop, an iteration controller feeds results from the previous round back into the next design. Here is a Python sketch of a simplified active-learning / Bayesian-style controller:
# loop_controller.py
from typing import Callable, List, Dict
class ClaudeLoopController:
def __init__(self, surrogate, oracle: Callable):
self.surrogate = surrogate # cheap model to rank candidates
self.oracle = oracle # real wet-lab experiment call
self.history: List[Dict] = []
def run(self, candidates: List[Dict], rounds: int = 3):
for _ in range(rounds):
scores = [(c, self.surrogate.predict(c)) for c in candidates]
scores.sort(key=lambda x: -x[1])
top = scores[0][0]
result = self.oracle(top) # dispatch robot + read sensor
self.history.append({"candidate": top, "y": result})
self.surrogate.update(self.history) # re-fit on real data
candidates = self.surrogate.suggest(
n=5, context=self.history[-5:])
return self.surrogate.best(self.history)
The essence is the “surrogate–oracle” alternation: use a cheap model to rank protein/molecule candidates, spend real experimental budget only on the top few, then re-fit the surrogate on real results. This is the engineering expression of the “learn” stage in a DBTL loop, echoing LUMI-lab’s “large-scale unsupervised modeling followed by iterative experiments” philosophy UHN Research.
Figure 3 isolates the iteration closed loop:
Figure 3 Data Return -> Model Fine-tuning / RL Iteration Loop
+----------+ wet truth +--------------+ gradient/reward +--------------+
| Sensor | -------------->| label/clean | -----------------> | Fine- tune / |
| Capture | | Clean/Label | | RL |
| (MS/Img/ | +------+-------+ +------+-------+
| qPCR) | | |
+----+-----+ v v
| +----------------+ +----------------+
| | Dataset Store |<--------------| updated Claude |
| | (versioned) | | (design next) |
| +----------------+ +-------+--------+
| | new batch
+---------------------------------------------------------------+-----> exp.
v
next DBTL round
The direct gain of this loop: truth data generated in the physical world can, in turn, fine-tune or reinforcement-learn Claude’s own scientific judgment, so the model gets increasingly good at foreseeing how a real experiment will unfold, compressing the “prediction–validation” gap. This is the technical landing of the strategic loop “AI closed-loop experiments → data return → model iteration.”
3.5 Wet-Lab Log Auditing: Borrowing the Offline-Monitoring Idea
The most overlooked yet most critical engineering aspect of an autonomous lab is auditability. Anthropic previously launched LSVP (Life Sciences Verification Program), whose core idea is an “offline monitoring + shared responsibility” framework that lets vetted scientific institutions use Claude for bioscience research under controlled conditions Claude Science. That idea maps directly onto wet-lab log auditing — every physical operation leaves a non-repudiable audit trail. Here is a Go implementation of the “experiment-operation log audit” core:
// audit.go
package audit
import (
"crypto/sha256"
"encoding/hex"
"time"
)
type Op struct {
Seq int64 `json:"seq"`
Device string `json:"device"`
Command string `json:"command"`
Params string `json:"params"`
Actor string `json:"actor"` // "claude" | "human" | "robot"
At time.Time `json:"at"`
PrevHash string `json:"prev_hash"`
Hash string `json:"hash"`
}
// appendHash links every physical op into an immutable chain,
// the audit equivalent of LSVP's offline-monitoring model.
func (o *Op) appendHash(prevHash string) {
o.PrevHash = prevHash
payload := o.encode()
sum := sha256.Sum256([]byte(payload))
o.Hash = hex.EncodeToString(sum[:])
}
By chaining every physical operation into an immutable hash chain, the moment an action crosses a boundary, the audit system — running in “offline-monitoring” mode — can trace back to which exact command was issued and by whom (Claude/human/robot). This is the engineering precondition that lets “Claude-directed experiments” and “strict safety auditing” coexist: put a traceable leash on autonomy so it can safely run fast.
4. The Human–Machine Collaboration Boundary: Freedom Within Safe Limits, Human Approval at State Changes
“Claude personally participating in experiment execution” is by no means unattended. For autonomy to be deployable, its boundary must be elastic. Combining Insilico’s Agent-Guard logic with Anthropic’s MHS safety-boundary design, a sensible human-machine collaboration division is shown in Figure 4:
Figure 4 Human-in-the-Loop Collaboration Division
+------------------------------------------------------------------+
| Autonomy Ladder |
| |
| Manual -> Co-Pilot -> Semi- -> High- -> Full auto |
| (collab) autonomous autonomous (restricted) |
| |
| Human-gated critical nodes (Checkpoint Gates): |
| - hypothesis & experimental goal setting |
| - dangerous reagent / biological-pathway operations |
| - cross-species / gene-editing decisions |
| - handling of unexpected results / anomalies |
| - re-review before any result is persisted/reported |
+------------------------------------------------------------------+
| Claude + robots autonomous within safe boundaries: |
| - orchestration of routine pipetting/incubation/imaging |
| - parameter tweaks & batch scheduling |
| - standard protocol execution & data acquisition |
| - fault self-check & backoff retry |
+------------------------------------------------------------------+
The core logic: the higher the risk and the more irreversible the node, the more it needs a human gate; the more repetitive, reversible, and standardized the operation, the more it is delegated to Claude + robots. Kauderer-Abrams has stressed that the company is “not competing with pharma and biotech companies that bring drugs to market” eet-china — for now focusing on early pre-clinical research and staying out of human clinical trials, which is itself a prudent boundary choice.
5. Safety and Compliance: When Models Enter the Physical World, Risk Assessment Must Upgrade
When a model begins to directly operate pipettors, centrifuges, incubators, and even pathways that could involve pathogens, the safety boundary must extend from “digital-world system prompt” to “devices, materials, and actual operations.” Three layers of risk are most critical here.
Layer one: dual-use risk. Anthropic has, in the past two weeks, disclosed that its systems were used in cases related to bioweapon development, and its internal researchers have publicly warned of extreme biosafety risks from AI eet-china. When Claude can actually execute biochemical experiments, the dual-use risk escalates from “generating dangerous sequence text” to “actually synthesizing dangerous substances.”
Layer two: data isolation and client-pipeline risk. Partner pharmas (Genentech, BMS, Novo Nordisk, etc.) worry that even with Anthropic’s promise of strict data isolation, their drug-discovery data could be used to strengthen the model behind Anthropic’s own pipeline. Kauderer-Abrams has publicly acknowledged this industry-wide concern eet-china.
Layer three: physical safety and integrity. Reagent ignition, robotic-arm gripping, culture contamination, sample mix-ups — these real-world “long-tail” accidents cannot be exhausted by software testing and must be caught by mechanisms such as “offline monitoring + shared responsibility.”
Figure 5 shows the isomorphic mapping of this safety framework onto LSVP’s offline-monitoring model:
Figure 5 Wet-Lab Safety Framework Isomorphic to LSVP Offline Monitoring
+----------------------------------------------------------------+
| LSVP (Life Sciences Verification Program) <-> Wet-Lab Safety|
| +-----------------------+ +--------------------------+ |
| | vetted institutions | | Claude directs robots | |
| | use Claude in bioscience| | in wet experiments | |
| +-----------+------------+ +------------+-------------+ |
| | offline monitor | full-operation logging |
| v v |
| +-----------------------+ +--------------------------+ |
| | model reasons in a | <-> | every physical op chained | |
| | controlled environment | | in immutable audit log | |
| +-----------+------------+ +------------+-------------+ |
| | shared responsibility | dual-use + physical |
| v safety review |
| +-----------------------+ +--------------------------+ |
| | institution/Anthropic | | human gates on dangerous | |
| | co-share compliance | | paths + pre-report review | |
| +-----------------------+ +--------------------------+ |
+----------------------------------------------------------------+
This isomorphism is crucial: LSVP solves “uncontrolled model reasoning”; the wet-lab safety framework solves “uncontrolled model action.” The former relies on environment isolation; the latter relies on “environment isolation + action auditing + human gates” as a triple guarantee. This is also why Anthropic dares to bring Claude into the physical world without letting it run completely unchecked.
6. Trend Assessment: AI Research Automation and the Future Drug-Development Path
Anthropic’s wet lab, layered on top of Insilico’s LabClaw, UHN’s LUMI-lab, DeepCure’s molecular foundry, XtalPi’s autonomous lab, and UvA’s RoboChem, is sketching a clear evolutionary path for AI research automation (Figure 6):
Figure 6 AI Research Automation Evolution Roadmap
Stage 1 Stage 2 Stage 3 Stage 4
Pure Computing -> Compute + -> Compute + -> Claude +
(Computational) External wet In-house wet Robots (closed loop)
------------------------------ --------------------------------
+ molecular generation + model designs + own validation + model-robot loop
+ DNA/protein sequences + outsourced make + shorter feedback + data return for
+ no real validation + rate limited by + human-limited + iteration
partners throughput + 24/7 autonomous
^ ^ ^ ^
| (most AI pharma today)| (DeepCure/LUMI/ | (Anthropic wet lab
| | XtalPi etc.) | direction / endgame)
+-------------------------------------------------------------+
| competitive focus shifts from "who designs faster" |
v to "who validates faster in the physical world & iterates" |
The core judgment: the competitive focus in AI pharma is shifting from “who can design candidate molecules faster” to “who can complete physical validation faster and feed results back into the next iteration” MITT Technology Review. Building on this, Figure 7 sketches Anthropic’s possible future automated drug-development path:
Figure 7 Future Automated Drug-Development Path
+----------------------------------------------------------------+
| hypothesis | design | build | test | learn/iterate |
| Claude reads| protein/ | auto synth/ | binding/ | data return |
| lit, new | mol gen | expression | functional| fine-tune |
| targets | sequence | robots exec | sensor | re-design |
| | | scoring | | read | |
| v v v v v |
| +------+ +--------+ +---------+ +--------+ +----------------+|
| | QID |>| design |->| synthesis|->| assay |->| AI loop ||
| |hypoth| | agent | | robots | | plat. | | (Bayesian/ ||
| | bank | |(Claude)| |(pipe/inc)| | (MS/img)| | active learn)||
| +------+ +--------+ +---------+ +--------+ +-------+--------+||
| ^ | ||
| +------------- multi-round convergence ---------+||
| ||
| bispecific/trispecific "undruggable" targets <- priority ||
+----------------------------------------------------------------+
A note of sobriety: even if AI can multiply pre-clinical R&D efficiency severalfold, from candidate molecule to marketed drug there remains an unbroken chain of rigorous safety and efficacy validation, and the vast majority of candidates will never pass clinical trials eet-china. Anthropic’s AI-pharma journey must still face the long test of real-world R&D laws. But its more immediate value may be to demonstrate to the entire AI-for-Science industry a positive loop combining “general-model capability + real physical experiments.”
7. Summary: The Decisive Leap From the Digital World to the Physical World
Anthropic’s wet lab in the Bay Area, on the surface a corporate strategy, is at its core a paradigm shift in engineering:
- A change in bottleneck awareness: the bottleneck in AI pharma has moved from “design” to “physical validation”; an in-house wet lab is essentially taking back control of the feedback-cycle system variable.
- A change in interface paradigm: through Model Hardware Standard, heterogeneous lab devices are abstracted into model-invocable capabilities, compressing integration time from weeks/months to hours/minutes.
- Closing the loop: genuinely walking the “Claude plans → robots execute → sensors return → Claude iterates” DBTL autonomous loop, letting physical truth data flow back to fine-tune the model itself.
- Upgrading safety: translating LSVP’s “offline monitoring + shared responsibility” into “action auditing + human gates,” balancing autonomy against auditability.
When Claude finally steps onto the bench, AI is no longer just “the computer that proposes designs” — it has, for the first time, become a research executor that controls physical devices, completes real experiments, and learns the truth back into itself. This step marks AI for Science truly moving out of the purely digital realm and into physical experimental scenarios. What is worth watching next is whether this positive loop can keep running with enough speed and low enough marginal cost — for that will determine whether AI-driven discovery remains a paper-bound idea or genuinely rewrites the underlying tempo of new-drug development.
（Note: This article is synthesized from public sources; the technical schemes are engineering-logic deductions, not official Anthropic implementation details.）